• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Vericel Corporation - Common Stock (NQ:VCEL)

    43.99 -1.08 (-2.40%)
    Streaming Delayed Price Updated: 11:34 AM EDT, Jun 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 122,705
    Open 45.32
    Bid (Size) 43.99 (100)
    Ask (Size) 44.15 (300)
    Prev. Close 45.07
    Today's Range 43.53 - 45.45
    52wk Range 28.95 - 46.62
    Shares Outstanding 46,631,158
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Vericel Stock Is Up 10%. Here's What This $402,000 Insider Sale Really Suggests ↗
    Focused on regenerative therapies for sports medicine and burn care, this biopharma firm reported a notable insider sale in June. 
    Via The Motley Fool
    Topics Regulatory Compliance
    Vericel Corp (NASDAQ:VCEL): A Classic Affordable Growth Stock in Biotech ↗
    Via Chartmill

    Performance

    YTD
    +23.5%
    +23.5%
    1 Month
    +34.0%
    +34.0%
    3 Month
    +44.0%
    +44.0%
    6 Month
    +17.0%
    +17.0%
    1 Year
    +3.4%
    +3.4%

    More News

    Read More
    News headline image
    Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
    From Biotech Insider
    Via GlobeNewswire
    News headline image
    The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
    From World Street Intelligence
    Via GlobeNewswire
    Vericel Corp (NASDAQ:VCEL): Growth and Technical Setup Align for Potential Breakout ↗
    Via Chartmill
    Vericel (NASDAQ:VCEL) Balances High Growth and Reasonable Valuation in Affordable Growth Screen ↗
    Via Chartmill
    Vericel Corp (NASDAQ:VCEL): A Prime Example of Affordable Growth ↗
    Via Chartmill
    Vericel Corp (NASDAQ:VCEL) Smashes Q1 Estimates, Raises Full-Year Outlook as MACI and Burn Care Surge ↗
    Via Chartmill
    Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Technical Setup Opportunity ↗
    Via Chartmill
    News headline image
    Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    MediWound (MDWD) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Vericel Corp (NASDAQ:VCEL) Emerges as a Top Affordable Growth Pick ↗
    Via Chartmill
    Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Breakout Case ↗
    Via Chartmill
    Vericel Corp (NASDAQ:VCEL) Reports Q4 2025 Earnings In Line, Beats on Profitability ↗
    Via Chartmill
    News headline image
    The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
    From Energy Metal News
    Via GlobeNewswire
    News headline image
    Vericel Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Vericel (VCEL) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
    From MediWound Ltd.
    Via GlobeNewswire
    News headline image
    Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel to Present at Multiple Upcoming Investor Conferences
    From Vericel Corporation
    Via GlobeNewswire
    News headline image
    Vericel (VCEL) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings

    Frequently Asked Questions

    Is Vericel Corporation - Common Stock publicly traded?
    Yes, Vericel Corporation - Common Stock is publicly traded.
    What exchange does Vericel Corporation - Common Stock trade on?
    Vericel Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Vericel Corporation - Common Stock?
    The ticker symbol for Vericel Corporation - Common Stock is VCEL on the Nasdaq Stock Market
    What is the current price of Vericel Corporation - Common Stock?
    The current price of Vericel Corporation - Common Stock is 43.99
    When was Vericel Corporation - Common Stock last traded?
    The last trade of Vericel Corporation - Common Stock was at 06/30/26 11:34 AM ET
    What is the market capitalization of Vericel Corporation - Common Stock?
    The market capitalization of Vericel Corporation - Common Stock is 2.05B
    How many shares of Vericel Corporation - Common Stock are outstanding?
    Vericel Corporation - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.